Transcription Factor 7/Like2 (TCF7/L2) Gene Associated With Metabolic Syndrome In The Type 2 Diabetes
DOI:
https://doi.org/10.36283/ziun-pjmd15-1/008Keywords:
TCF7L2 (Transcription factor 7 L2), Proliferative diabetic retinopathyAbstract
Background: Diabetic retinopathy (DR) is a chronic complication of diabetes mellitus which can be due to micro vascular changes occurring in retina due to hyperglycemia. Polymorphism in gene TCF7L2 rs7903146 has been shown to increase susceptibility to developing diabetes mellitus.
Aim: Association between Diabetic retinopathy (DR) and polymorphism of TCF7L2 expression and alteration in VEGF expression level has also been found in Type2 DM.
Method: A comparative research was carried out in the Department of Biochemistry, with 148 volunteers aged 18 to 50 recruited from the Baqai Institute of Diabetology and Endocrinology (BIDE). Clinical data, anthropometric measures, and biochemical markers such FBS, OGTT, HbA1c, and lipid profile were obtained. Genomic DNA was collected, and the TCF7L2 gene polymorphism (rs7903146) was examined by Sanger sequencing.
Results: The study analyzed 148 Type 2 Diabetes mellitus (T2DM) patients with and without retinopathy, with a mean age of 43.27±9.45 years. Results showed significant differences in blood pressure, fasting blood glucose, HbA1c, triglycerides, and cholesterol levels between groups. The TT genotype was more abundant in group B, while the CT genotype was higher in group A. The majority of T2DM patients with retinopathy had complications like retinal hemorrhages, microdot, and blindness.
Conclusion: Overall, the homozygous TT genotype of TCF7L2 rs7903146 polymorphism was found dominant in T2DM subjects with retinopathy as compared with T2DM without retinopathy, and CT genotype was found higher in T2DM subjects without retinopathy and healthy individuals. We also found mutant T allele was predominantly higher in T2DM subjects with and without retinopathy.
References
REFERENCES
1. Group AS, Group AES. Effects of medical therapies on retinopathy progression in type 2 diabetes. New England Journal of Medicine. 2010;363(3):233-44.
2. Acharya S, Al-Elq A, Al-Nafaie A, Muzaheed M, Al-Ali A. Type 2 diabetes mellitus susceptibility gene TCF7L2 is strongly associated with hyperglycemia in the Saudi Arabia Population of the eastern province of Saudi Arabia. European Review for Medical & Pharmacological Sciences. 2015;19(16).
3. Al-Maskari F, El-Sadig M. Prevalence of diabetic retinopathy in the United Arab Emirates: a cross-sectional survey. BMC ophthalmology. 2007;7(1):11.
4. Alnahdi A, Alghamdi A, Alkandari K, Alsamir A, Alsomali A. Retinopathies: Types, Etiologies, and Outcome. 2022.
5. Aronow WS. Commentary on treatment of hypertension in the elderly. Cardiovascular drugs and therapy. 2001;15(3):281-2.
6. Begriche K, Massart J, Robin MA, Bonnet F, Fromenty B. Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease. Hepatology. 2013;58(4):1497-507.
7. Beloso C, Souto J, Fabregat M, Romanelli G, Javiel G, Mimbacas A. Association of TCF7L2 mutation and atypical diabetes in a Uruguayan population. World Journal Of Diabetes. 2018;9(9):157.
8. Bhavsar AR, Googe JM, Stockdale CR, Bressler NM, Brucker AJ, Elman MJ, et al. Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials. Archives of ophthalmology. 2009;127(12):1581-3.
9. Bos M, Agyemang C. Prevalence and complications of diabetes mellitus in Northern Africa, a systematic review. BMC public health. 2013;13(1):387.
10. Bozkurt L, Göbl CS, Tura A, Chmelik M, Prikoszovich T, Kosi L, et al. Fatty liver index predicts further metabolic deteriorations in women with previous gestational diabetes. PloS one. 2012;7(2):e32710.
11. Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Physical therapy. 2008;88(11):1322-35.
12. Callaghan BL, Richardson R. Early experiences and the development of emotional learning systems in rats. Biology of Mood & Anxiety Disorders. 2013;3(1):8.
13. Chen J, Stahl A, Krah NM, Seaward MR, Dennison RJ, Sapieha P, et al. Wnt signaling mediates pathological vascular growth in proliferative retinopathy. Circulation. 2011;124(17):1871-81.
14. Chen X, Ayala I, Shannon C, Fourcaudot M, Acharya NK, Jenkinson CP, et al. The diabetes gene and Wnt pathway effector TCF7L2 regulates adipocyte development and function. Diabetes. 2018;67(4):554-68.
15. Cheng S-L, Ramachandran B, Behrmann A, Shao J-S, Mead M, Smith C, et al. Vascular smooth muscle LRP6 limits arteriosclerotic calcification in diabetic LDLR−/− mice by restraining noncanonical Wnt signals. Circulation research. 2015;117(2):142-56.
16. Cherney DZ, Scholey JW, Sochett E, Bradley TJ, Reich HN. The acute effect of clamped hyperglycemia on the urinary excretion of inflammatory cytokines/chemokines in uncomplicated type 1 diabetes: a pilot study. Diabetes care. 2011;34(1):177-80.
17. Chew EY, Klein ML, Ferris FL, Remaley NA, Murphy RP, Chantry K, et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy: Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Archives of ophthalmology. 1996;114(9):1079-84.
18. Ciccacci C, Di Fusco D, Cacciotti L, Morganti R, D’Amato C, Novelli G, et al. TCF7L2 gene polymorphisms and type 2 diabetes: association with diabetic retinopathy and cardiovascular autonomic neuropathy. Acta diabetologica. 2013;50(5):789-99.
19. Clevers H. Wnt/β-catenin signaling in development and disease. Cell. 2006;127(3):469-80.
20. Combs TP, Marliss EB. Adiponectin signaling in the liver. Reviews in Endocrine and Metabolic Disorders. 2014;15(2):137-47.
21. da Silva Xavier G, Loder MK, McDonald A, Tarasov AI, Carzaniga R, Kronenberger K, et al. TCF7L2 regulates late events in insulin secretion from pancreatic islet β-cells. Diabetes. 2009;58(4):894-905.
22. Davoudi S, Sobrin L. Novel genetic actors of diabetes-associated microvascular complications: retinopathy, kidney disease and neuropathy. The Review of Diabetic Studies: RDS. 2015;12(3-4):243.
23. Viigimaa M, Sachinidis A, Toumpourleka M, Koutsampasopoulos K, Alliksoo S, Titma T. Macrovascular complications of type 2 diabetes mellitus. Current vascular pharmacology. 2020;18(2):110-6.
24. Giri B, Dey S, Das T, Sarkar M, Banerjee J, Dash SK. Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: An update on glucose toxicity. Biomedicine & pharmacotherapy. 2018;107:306-28.
25. Mrugacz M, Bryl A, Zorena K. Retinal vascular endothelial cell dysfunction and neuroretinal degeneration in diabetic patients. Journal of clinical medicine. 2021;10(3):458.
26. Kusuhara S, Fukushima Y, Ogura S, Inoue N, Uemura A. Pathophysiology of diabetic retinopathy: the old and the new. Diabetes & metabolism journal. 2018;42(5):364.
27. Singh D, Tripathy K. Retinal macroaneurysm. 2022.
28. Liu J, Hu H, Qiu S, Wang D, Liu J, Du Z, et al. The prevalence and risk factors of diabetic retinopathy: screening and prophylaxis project in 6 provinces of China. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2022:2911-25.
29. Tokuda Y, Tabuchi H, Nagasawa T, Tanabe M, Deguchi H, Yoshizumi Y, et al. Automatic diagnosis of diabetic retinopathy stage focusing exclusively on retinal hemorrhage. Medicina. 2022;58(11):1681.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Pakistan Journal of Medicine and Dentistry
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY) 4.0 https://creativecommons.org/licenses/by/4.0/
Metrics
How to Cite
